{
    "eid": "2-s2.0-85016004765",
    "title": "Oxidative and nitrosative stress biomarkers in chronic schizophrenia",
    "cover-date": "2017-07-01",
    "subject-areas": [
        {
            "$": "Biological Psychiatry",
            "@code": "2803"
        },
        {
            "$": "Psychiatry and Mental Health",
            "@code": "2738"
        }
    ],
    "keywords": [],
    "authors": [
        "Karine Maria Boll"
    ],
    "citedby-count": 44,
    "ref-count": 53,
    "ref-list": [
        "Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study",
        "Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia",
        "Remission in schizophrenia: Proposed criteria and rationale for consensus",
        "Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia",
        null,
        "Modulation of paraoxonase 1 and protein N-homocysteinylation by leptin and the synthetic liver X receptor agonist T0901317 in the rat",
        "Plasma paraoxonase, health, inflammatory conditions, and liver function in transition dairy cows",
        "Oxidative stress in schizophrenia",
        "Clozapine and olanzapine are better antioxidants than haloperidol, Quetiapine, Risperidone and ziprasidone in in vitro models",
        "Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug na\u00efve first episode psychosis",
        "Oxidative stress and neopterin abnormalities in schizophrenia: A longitudinal study",
        "Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia",
        "Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: The hunt goes on",
        "Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia",
        "Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries",
        "Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response",
        "Meta-analysis of oxidative stress in schizophrenia",
        "Hydroperoxide-initiated chemiluminescence: An assay for oxidative stress in biopsies of heart, liver, and muscle",
        "Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia",
        "Total antioxidant capacity as a tool to assess redox status: Critical view and experimental data",
        "Improved detection of advanced oxidation protein products in plasma",
        "Similar immune profile in bipolar disorder and schizophrenia: Selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor",
        "Implications for reactive oxygen species in schizophrenia pathogenesis",
        "Antipsychotic Treatment Reduces Indices of Oxidative Stress in First-Episode Psychosis Patients",
        "Inflammation in schizophrenia: A question of balance",
        "Oxidative stress and role of antioxidant and \u03c9-3 essential fatty acid supplementation in schizophrenia",
        "Impaired mitochondrial function in psychiatric disorders",
        "Meta-analysis of cytokine alterations in schizophrenia: Clinical status and antipsychotic effects",
        "Oxidative & nitrosative stress in depression: Why so much stress?",
        "Semiautomated measurement of nitrate in biological fluids",
        "Regulation of interleukin-6 and leptin in schizophrenia patients: A preliminary analysis",
        "High predictive value of immune-inflammatory biomarkers for schizophrenia diagnosis and association with treatment resistance",
        "Oxidative stress in drug na\u00efve first episode psychosis and antioxidant effects of risperidone",
        "Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy",
        "Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity",
        "Inflammatory Cytokine Alterations in Schizophrenia: A Systematic Quantitative Review",
        "Oxidative stress in blood of HIV infected patients",
        "Determination of paraoxonase 1 status without the use of toxic organophosphate substrates.",
        "Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: Effects of short term antipsychotic treatment",
        "Coronary artery disease risk factors in patients with schizophrenia: Effects of short term antipsychotic treatment",
        "First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment",
        "Uric acid: The oxidant-antioxidant paradox",
        "Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis",
        "Protein S-nitrosylation: Role for nitric oxide signaling in neuronal death",
        "Oxidative stress and DNA damage in untreated first-episode psychosis in adolescents",
        "Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism",
        "Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: A systematic review of biomarker studies",
        "Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis",
        "Increased serum levels of CCL11/eotaxin in schizophrenia",
        "Changes in oxidative stress markers in patients with schizophrenia: The effect of antipsychotic drugs",
        "Associations of oxidative stress status parameters with traditional cardiovascular disease risk factors in patients with schizophrenia",
        "The ageing systemic milieu negatively regulates neurogenesis and cognitive function",
        "BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Plovdiv",
            "affilname": "Medical University of Plovdiv",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Londrina",
            "affilname": "Universidade Estadual de Londrina",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Geelong",
            "affilname": "Deakin University",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Universidade Federal de S\u00e3o Paulo",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Sao Paulo",
            "affilname": "Faculdade de Ciencias Medicas da Santa Casa de Sao Paulo",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Waalre",
            "affilname": "Revitalis",
            "affiliation-country": "Netherlands"
        }
    ],
    "funding": []
}